Nirvana Life Sciences Inc.
CNQ: NIRV.CN0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Canadian Securities Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Bruce Clark
- Headquarters
- Vancouver, Canada
- IPO year
- 2022
- Market cap
- CA$337.6K
- Website
- https://nirvanalifesciences.com
Loading NIRV…
Loading profile data…Frequently asked questions about NIRV
What does Nirvana Life Sciences Inc. (NIRV.CN) do?
Nirvana Life Sciences Inc. engages in the scientific research and development of therapeutic products derived from psychedelics. It also focuses on developing methodologies for extraction and purification of psychoactive compounds; and the improvement of propagation techniques for growing such biomass on a large scale. The company was incorporat...
Where does NIRV.CN trade?
Nirvana Life Sciences Inc. (NIRV.CN) trades on the Canadian Securities Exchange.
What sector is NIRV.CN in?
Nirvana Life Sciences Inc. (NIRV.CN) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Nirvana Life Sciences Inc.?
Bruce Clark is the chief executive officer of Nirvana Life Sciences Inc. (NIRV.CN).
Where is Nirvana Life Sciences Inc. headquartered?
Nirvana Life Sciences Inc. is headquartered in Canada.
Does NIRV.CN pay a dividend?
Nirvana Life Sciences Inc. (NIRV.CN) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did NIRV.CN go public?
Nirvana Life Sciences Inc. (NIRV.CN) completed its initial public offering in 2022.